Mounjaro Side Effects And Safety

Mounjaro is well studied. The clinical trials enrolled tens of thousands of people, and the medication has been in real world use globally since 2022. The safety profile is reasonably well understood. Most side effects are predictable, manageable, and improve with time. A small number are uncommon but serious enough that they need to be on your radar.

The Most Common Side Effects

These affect a majority of people at some point during treatment, usually most strongly in the first month and after dose increases.

Gastrointestinal effects

• Nausea. The most common. Often described as feeling full or queasy rather than 'about to vomit'. Usually settles within the first month.
• Vomiting. Less common than nausea but does happen, particularly after large or rich meals.
• Diarrhoea or constipation. Either can occur. Both usually settle within weeks.
• Indigestion. Reflux, bloating, fullness after small meals.
• Abdominal pain. Mild to moderate. Severe persistent pain is a different matter (see pancreatitis below).

Other common effects

• Reduced appetite (the intended effect, often noticed as a symptom)
• Fatigue, particularly in the first month
• Injection site reactions (redness, itching, small bruise)
• Hair shedding (related to weight loss, not the medication directly)
• Reduced taste sensitivity
• Burping

Managing The Common Side Effects

Most people get through the early weeks with small adjustments rather than stopping. Useful approaches:

• Smaller meals, eaten more slowly
• Stop eating when comfortable, not full
• Reduce fatty, greasy, or heavily processed foods which make nausea worse
• Stay hydrated, particularly with electrolytes if vomiting or diarrhoea
• Bland easy to digest foods in the first day or two after injection if nausea is bad
• Ginger tea, peppermint tea, or plain biscuits help some people with nausea
• Anti-nausea medication if the doctor decides it is appropriate

See the side effect management blog post for more detail.

Less Common But Serious Side Effects

Gallbladder problems

Increased risk of gallstones and gallbladder inflammation, particularly during periods of significant weight loss. Symptoms include upper right abdominal pain (often worse after fatty meals), nausea, and sometimes yellowing of the skin or eyes. Worth raising with the treating doctor.

Diabetic retinopathy worsening

Rapid blood glucose improvement can occasionally cause temporary worsening of existing diabetic eye disease. For people with diabetes and known retinopathy, baseline assessment before starting is recommended.

Acute kidney injury

Usually secondary to dehydration from severe vomiting or diarrhoea. Maintaining hydration is the protective factor. Pre-existing kidney disease needs monitoring.

Severe allergic reaction

Rare but possible. Difficulty breathing, swelling of the face, lips, or tongue, severe rash. Medical emergency.

Thyroid C-cell tumours

Observed in rat studies. Relevance to humans is unclear. As a precaution, the medication is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2).

When Mounjaro Is Not Suitable

The medication is contraindicated or used with caution in:

• Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• Type 1 diabetes (not indicated)
• Diabetic ketoacidosis
• Severe gastrointestinal disease, particularly gastroparesis
• Pregnancy or breastfeeding (not used)
• Active pancreatitis or history of pancreatitis
• Severe kidney impairment (caution, may need dose adjustment)
• Severe liver disease (limited data)
• Severe gallbladder disease
• History of eating disorders (case by case assessment)
• Children under 18 (not approved)

Drug Interactions

Oral medications

Tirzepatide slows gastric emptying. This means oral medications can be absorbed more slowly. For most medications this does not matter clinically, but a few specifics:

• Oral contraceptives. Absorption may be reduced. Additional contraception is recommended for four weeks after starting Mounjaro and after each dose increase, or switching to a non oral method.
• Narrow therapeutic index drugs (warfarin, levothyroxine, some seizure medications). Worth monitoring more closely.

Insulin and sulfonylureas

Combined use can cause hypoglycaemia. The treating doctor usually reduces the dose of the older medication when starting Mounjaro.

Alcohol

Not a direct interaction but heavy drinking increases nausea, dehydration, and pancreatitis risk. Most people find they want less alcohol on Mounjaro anyway.

Pregnancy And Contraception

Mounjaro is not used in pregnancy. Animal data shows potential fetal harm. Women planning pregnancy should stop the medication at least one month before trying to conceive.

Effective contraception is recommended for women of childbearing age who are using Mounjaro. Because oral contraceptive absorption can be reduced, non oral methods (IUDs, injection, ring) are often preferred. Backup contraception is recommended for the first four weeks of treatment and after each dose increase if continuing oral pills.

What To Tell The Consulting Doctor

Before starting, the doctor needs to know about:

• All current medications, including over the counter and supplements
• Any history of pancreatitis, gallbladder disease, or thyroid issues
• Any history of eating disorders
• Pregnancy status or plans to conceive
• Other major medical conditions (kidney, liver, gut, eye)
• Family history of medullary thyroid cancer or MEN2
• Recent surgical history
• Mental health history relevant to body image and eating

Be straight at the consultation. The doctor cannot make a safe decision without an accurate picture, and there is no judgement.

Frequently Asked